Mumbai: Indira IVF connects with Presagen To release the latest Artificial Intelligence (AI) toolLife WhispererAt their 100+ clinics across the country. This AI tool helps improve embryo selection in in-vitro fertilization (IVF) and provides an increased predictability of pregnancy thus, reducing the number of cycles required for successful conception.
Tested internationally, Life Whisper uses AI to assess two embryo quality metrics, Life Whisper Viability, which assesses whether an embryo can lead to conception, and Life Whisper Genetics, which non-invasively assesses the genetic integrity of the embryo.
Speaking on the development, Indira IVF Co-Founder and Managing Director Dr. Nitiz Murdia said, “With Life Whisperer, we will be able to provide additional transparency and confidence to our patients around. IVF procedure By providing them with a report on the AI results of their embryos. With the aim of improving IVF outcomes for patients in India, our organization will continue to bridge every gap in the way of quality fertility treatment in the country.”
Indira IVF co-founder and CEO Dr. Kshitiz Murdia said, “We are delighted to be able to incorporate this new technology which will definitely increase the success rate of IVF procedures. Life Whisperer will help embryologists make objective decisions on the best embryos needed for conception. It will ensure that couples have the greatest chance of starting a new family sooner.”
Commenting on the agreement, Dr Michele Perugini, CEO of Pressagen, said, “We are thrilled to be working with Indira IVF to help them integrate the most technically advanced and well-tested AI technology into their IVF treatment processes. Indira IVF and Presagen have a long-term partnership to advance the advancement of AI in fertility.”
Life Whisperer is currently authorized for sale in more than 40 countries worldwide, with India being the main market. It is supported by extensive scientific evidence, clinical data and numerous recent publications, including two in Nature Scientific Reports, two in Human Reproduction and a recent paper in Reproductive Biomedicine Online (RBMO), and is regularly presented at global fertility meetings. European Society of Human Reproduction and Embryology (ESHRE) and American Society for Reproductive Medicine (ASRM).
